78 related articles for article (PubMed ID: 12058230)
1. Antibody Engineering for Nuclear Imaging and Radioimmunotherapy.
Rodriguez C; Delaney S; Sarrett SM; Keinänen OM; Zeglis BM
J Nucl Med; 2022 Sep; 63(9):1316-1322. PubMed ID: 35863894
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-enabled quantification of simultaneous PET/MRI for cell transplantation monitoring.
Hayat H; Wang R; Sun A; Mallett CL; Nigam S; Redman N; Bunn D; Gjelaj E; Talebloo N; Alessio A; Moore A; Zinn K; Wei GW; Fan J; Wang P
iScience; 2023 Jul; 26(7):107083. PubMed ID: 37416468
[TBL] [Abstract][Full Text] [Related]
3. (211)Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy.
Burtner CR; Chandrasekaran D; Santos EB; Beard BC; Adair JE; Hamlin DK; Wilbur DS; Sandmaier BM; Kiem HP
Hum Gene Ther; 2015 Jun; 26(6):399-406. PubMed ID: 25919226
[TBL] [Abstract][Full Text] [Related]
4. Defining the intensity of conditioning regimens: working definitions.
Bacigalupo A; Ballen K; Rizzo D; Giralt S; Lazarus H; Ho V; Apperley J; Slavin S; Pasquini M; Sandmaier BM; Barrett J; Blaise D; Lowski R; Horowitz M
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1628-33. PubMed ID: 19896087
[TBL] [Abstract][Full Text] [Related]
5. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.
Wong JY; Rosenthal J; Liu A; Schultheiss T; Forman S; Somlo G
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):273-9. PubMed ID: 18786784
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia.
Koenecke C; Hofmann M; Bolte O; Gielow P; Dammann E; Stadler M; Franzke A; Boerner AR; Eder M; Ganser A; Knapp W; Hertenstein B
Int J Hematol; 2008 May; 87(4):414-421. PubMed ID: 18415659
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for acute myeloid leukemia.
Jurcic JG
Curr Oncol Rep; 2005 Sep; 7(5):339-46. PubMed ID: 16091194
[TBL] [Abstract][Full Text] [Related]
8. The use of radioimmunoconjugates in stem cell transplantation.
Pagel JM; Matthews DC; Appelbaum FR; Bernstein ID; Press OW
Bone Marrow Transplant; 2002 May; 29(10):807-16. PubMed ID: 12058230
[TBL] [Abstract][Full Text] [Related]
9. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
Press OW
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma.
Inwards DJ; Cilley JC; Winter JN
Best Pract Res Clin Haematol; 2006; 19(4):669-84. PubMed ID: 16997176
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective.
Press OW
Semin Oncol; 2003 Apr; 30(2 Suppl 4):10-21. PubMed ID: 12728403
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoconjugates in acute leukemia treatment: the future is radiant.
Kotzerke J; Bunjes D; Scheinberg DA
Bone Marrow Transplant; 2005 Dec; 36(12):1021-6. PubMed ID: 16247432
[TBL] [Abstract][Full Text] [Related]
13. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
Amadori S; Stasi R
Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
